Board Advisor Mary Gunn on how CROs are evolving under rising delivery pressure - and why execution credibility, governance, and leadership depth now matter more than scale alone.
Market Insight
From Uncertainty to Impact: Building What You Believe In
John Buckels almost left diagnostics for good - until the right opportunity at Genetic Signatures reignited his belief that the right people, at the right time, can change everything.
Market Insight
Six Years of Leadership: Building CND Life Sciences from Science to Scale
After six years leading CND Life Sciences, CEO Rick Morello reflects on turning a scientific innovation into a national diagnostic platform - and why the right team is critical to scaling impact.
.jpeg)
